The results showed that TP53 was altered in 88% of gastric cancer samples, with the majority of mutations being missense mutations (green bars), followed by frame shift deletions (orange bars) and splice site mutations (blue bars) (Fig. 3A-B-C). The gene discussed is TP53; the disease is gastric cancer.